Carl read the papersWhat it actually is
KLOW is a fixed combination of KPV, GHK-Cu, BPC-157 and TB-500 — the name is an acronym of its parts. Total peptide content is typically 80 mg per vial.
The rationale is practical rather than scientific. Each of the four has its own following for repair, inflammation or skin, and people were already running them together. Combining them means one reconstitution, one injection and one set of maths instead of four.
How it’s thought to work
- BPC-157 — The local repair signal — angiogenesis, fibroblast migration, gut lining protection.
- TB-500 — The systemic counterpart — actin regulation and cell migration, spreading widely rather than acting locally.
- GHK-Cu — The copper peptide — collagen synthesis, tissue remodelling and skin repair.
- KPV — The anti-inflammatory element — a tripeptide fragment of alpha-MSH, studied mostly for gut and systemic inflammation.
What the research says
There is no research on KLOW as a blend. What exists is the individual evidence for each of the four, and that evidence varies considerably in quality — BPC-157 and TB-500 have substantial animal literature and thin human data, GHK-Cu has the strongest skin research of the group, and KPV is the least studied. Nobody has tested this combination or this ratio.
- No studies exist on the combination itself — only on the four components separately.
- BPC-157 and TB-500 are the classic recovery pairing, with substantial rodent literature behind them.
- GHK-Cu carries the best-documented research of the four, mostly in skin and wound healing.
- KPV is the least studied component, principally investigated for intestinal inflammation.
Watch: KLOW Blend explained
Video by Living Youthful on YouTube. Not affiliated with Peptide Carl and not an endorsement — included because a second explanation of the same mechanism is often what makes it click.
Reported protocols
These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.
| Parameter | Commonly reported range |
|---|---|
| Typical vial | 80 mg total across the four components |
| Reconstitution | Larger volumes are usual for blends — the concentration maths is per-vial rather than per-compound, which is the main practical difference |
| Frequency | Generally follows the BPC/TB-500 pattern the components are usually run on |
| Route | Subcutaneous, rotating sites |
| Cycle | 4–8 weeks is the usual described run, following the component protocols |
| Community tip | The recurring warning is about the fixed ratio. If one component does not suit you, you cannot reduce it without reducing all four — and if you want more of one, you get more of everything. People who want control run separate vials. |
Common use cases
| Goal | Community protocol notes |
|---|---|
| General repair with an inflammatory component | the four-compound version, following the BPC/TB-500 cadence |
| Convenience over control | one reconstitution instead of four — at the cost of independent dosing |
| When separate vials make more sense | if you need to adjust one compound without moving the others |
Mixing it (reconstitution)
Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.
→ Open the Reconstitution Calculator
Injection & handling
Subcutaneous, rotating sites — the same practice as the components individually. The practical difference with a blend is the arithmetic: your dose is a fraction of the whole vial rather than a calculated amount of one compound, so the reconstitution volume determines everything and there is no way to adjust one component without moving all four. Blends generally take a larger reconstitution volume than a single-compound vial — the blends calculator works out what each draw actually delivers across all four. Refrigerate once reconstituted and use within about 28 days.
Stacks it appears in
- It is already a stack — Adding BPC-157 or TB-500 separately on top means double-dosing components already in the vial.
- Separate vials instead — Four reconstitutions and four sets of maths, in exchange for independent control of each compound.
